The New Sentinel Network — Improving the Evidence of Medical-Product Safety  

Oleh:

Platt, Richard ; Wilson, Marcus ; Chan, K. Arnold ; Benner, Joshua S.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 361 no. 07 (Aug. 2009), page 645-646.
Topik: The New Sentinel Network — Improving the Evidence of Medical-Product Safety

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2009.04 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

In 2007, Congress directed the Food and Drug Administration (FDA) to create a new postmarketing surveillance system that will, by 2012, be using electronic health data from 100 million people to prospectively monitor the safety of marketed medical products. This new system is intended to complement existing systems of "spontaneous" adverse-event reporting. In May 2008, the FDA announced the Sentinel Initiative, which would "access the capabilities of multiple, existing data systems (i.e., electronic health record systems, medical claims databases)." The network of data systems is intended both to detect signals (i.e., higher-than-expected rates of adverse outcomes) and to confirm signals, including those suggested by other sources, and to do so rapidly and quantitatively. At a recent Senate hearing before her confirmation, FDA Commissioner Margaret Hamburg stated that close postmarketing monitoring of medical-product safety would remain a high priority during her tenure.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali